KOOL News Alert Thermogenesis (KOOL) 1.13 12/25/2014 15:47:5

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Thermogenesis (KOOL) 1.13 $KOOL

Cell Therapy 2015: With Maturity Comes Promise
Life Sciences Report - Seeking Alpha - Wed Dec 24, 6:41AM CST
A number of new and innovative medical paradigms are being explored by companies in the life sciences sector, with one of the front-runners being cell therapy - a disruptive technology that has, in the past few years, progressed out of preclinical...
KOOL: 1.13 (+0.04), AGEN: 3.85 (unch), INO: 9.11 (-0.09), NBS: 3.27 (+0.02), OSIR: 14.87 (+0.13), TEVA: 57.09 (+0.33), ATHX: 1.30 (-0.03)

Cesca Therapeutics names Denis Michael Rhein to board
M2 - Mon Dec 08, 6:01AM CST
Medicine company Cesca Therapeutics (NasdaqCM:KOOL) said on Friday that Denis Michael Rhein has been elected to its board of directors.
KOOL: 1.13 (+0.04)

Cesca Therapeutics Appoints Mr. Denis Michael Rhein to Its Board of Directors
GlobeNewswire - Fri Dec 05, 4:59AM CST
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced that Mr. Denis Michael Rhein (54) has been appointed to the Company's Board of Directors.
KOOL: 1.13 (+0.04), DB: 30.95 (+0.04)

Cesca Therapeutics Invited to Present at LD Micro Conference and the World Stem Cell Summit
GlobeNewswire - Wed Nov 26, 5:24AM CST
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company announced today that the Company will present at the LD Micro Conference on Tuesday, December 2nd and at the World Stem Cell Summit on Wednesday, December 3rd.
KOOL: 1.13 (+0.04)

Cesca up on IDE filing
Seeking Alpha - at Seeking Alpha - Thu Nov 20, 2:50PM CST

KOOL: 1.13 (+0.04)

Cesca Therapeutics Announces Filing of U.S. Pivotal IDE Application for No-Option Critical Limb Ischemia ("CLI"
GlobeNewswire - Thu Nov 20, 5:34AM CST
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company developing proprietary devices and methods for cardiovascular, orthopedic and hematological/oncological procedures, today announced it has submitted an investigational device exemption ("IDE" application to the U.S. Food and Drug Administration ("FDA" for a pivotal multicenter study of the Company's SurgWerks-CLI and VXP System ("SURGWERKS-CLI" for treating advanced stages of no-option lower limb critical limb ischemia. The IDE application is the result of two prior positive pilot and feasibility studies conducted in Italy and India, respectively, and collaborative pre-IDE feedback from the U.S. FDA.
KOOL: 1.13 (+0.04)

Cesca Therapeutics' (KOOL) CEO Robin Stracey on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 15, 12:39AM CST

KOOL: 1.13 (+0.04)

Cesca Therapeutics misses by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 3:16PM CST

KOOL: 1.13 (+0.04)

Cesca Therapeutics Reports First Quarter Fiscal 2015 Results
GlobeNewswire - Thu Nov 13, 3:09PM CST
Company Completes Its Pivotal Clinical Trial Protocol for Treating Patients With Critical Limb Ischemia for Submission to the FDA
KOOL: 1.13 (+0.04)

Cesca reports tomorrow
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 8:29AM CST

KOOL: 1.13 (+0.04)

Cesca Therapeutics to Announce First Quarter Fiscal 2015 Results on November 13, 2014
GlobeNewswire - Wed Nov 12, 5:00AM CST
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, announced today it will report financial results for the fiscal first quarter ended September 30, 2014, on Thursday, November 13, 2014.
KOOL: 1.13 (+0.04)

Cesca Therapeutics Announces Change in Executive Leadership
GlobeNewswire - Wed Oct 29, 8:11AM CDT
Cesca to Search for Industry Veteran to Advance its Clinical and Commercialization Strategy
KOOL: 1.13 (+0.04)

Cesca Therapeutics Shareholders Reporting Group File 13D
Marketwired - Mon Oct 27, 10:02AM CDT
A Schedule 13D has been filed with the U.S. Securities and Exchange Commission on behalf of a group of shareholders in Cesca Therapeutics, a company formed by the merger earlier this year of leading cell-therapy device-maker ThermoGenesis Corp. and regenerative medicine clinical therapy company TotipotentRX, engaged in the research, development, and commercialization of point-of-care cell-based therapeutics for use in multiple chronic medical illnesses, including critical limb ischemia and acute myocardial infarction.
KOOL: 1.13 (+0.04)

Cesca Therapeutics to provide blood storage, processing and consumable platform to Upstate Cord Blood BankCesca
M2 - Mon Oct 13, 8:40AM CDT
Medicine company Cesca Therapeutics (NasdaqCM:KOOL) reported on Monday the receipt of an agreement to provide its cell storage, processing and consumables platform to Upstate Medical University's, Upstate Cord Blood Bank located in New York State, USA.
KOOL: 1.13 (+0.04)

Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank
GlobeNewswire - Mon Oct 13, 5:00AM CDT
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has successfully secured a contract to provide its cell storage, processing and consumables platform to Upstate Medical University's, Upstate Cord Blood Bank, one of two public blood cord banks in New York State and one of 27 total public cord blood banks in the United States.
KOOL: 1.13 (+0.04)

Cesca Therapeutics to Present at Stem Cell Meeting on the Mesa
GlobeNewswire - Mon Oct 06, 5:00AM CDT
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company announced today that Kenneth Harris the Company's President will present at the 4 Annual Stem Cell Meeting on the Mesa to be held October 7-9 in La Jolla, CA.
KOOL: 1.13 (+0.04)

Cesca Therapeutics passes TFDA's approval for sale of AXP AutoXpress System in Taiwan
M2 - Mon Sep 29, 6:27AM CDT
Regenerative medicine company Cesca Therapeutics (NasdaqCM:KOOL) reported on Monday that it has received approval from the Taiwan Food and Drug Administration (TFDA) for the sale and distribution of its AXP AutoXpress System and related cell processing bag-set in Taiwan.
KOOL: 1.13 (+0.04)

Cesca Therapeutics Announces Approval of Its AXP(R) AutoXpress(R) System in Taiwan
GlobeNewswire - Mon Sep 29, 5:05AM CDT
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has received approval from the Taiwan Food and Drug Administration ("TFDA" for the sale and distribution of its AXP AutoXpress System and related cell processing bag-set in Taiwan.
KOOL: 1.13 (+0.04)

Cesca Therapeutics Reports Fourth Quarter and Full Fiscal 2014 Results
GlobeNewswire - Mon Sep 29, 5:00AM CDT
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today reported financial results for the fourth quarter and year-ended fiscal 2014.
KOOL: 1.13 (+0.04)

Cesca Therapeutics Reschedules Fourth Quarter and Full Year Earnings Release
GlobeNewswire - Thu Sep 25, 3:30PM CDT
Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, announced today that it is rescheduling its previously announced earnings conference call for fiscal year end 2014. The Company intends to reschedule the conference call to provide additional time necessary to finalize its accounting for income taxes associated with purchase accounting for the merger with TotipotentRX, which is a non-cash item. The original conference call was scheduled for today, September 25, 2014 at 2:00 PM Pacific (5:00 PM Eastern).
KOOL: 1.13 (+0.04)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Skanska Adds $80M U.S. Tech Facility Contract to Orders

Updated Category News Views 16

An $80 million add-on is the sort of construction news that looks modest until you remember what it says about the customer relationship. Skanska has won an additional contract from an existing client for a U.S. tech facility, worth roughly SEK 760 million, and it will enter U.S. order bookings in the fourth quarter of 2026. No fireworks, no grand strategic...

Continue Reading
GALLS Honors Service With Lexington Hall of Fame Wall

Updated Category News Views 111

A headquarters wall can say more about a company than another polished mission statement ever will. On November 17, 2026, GALLS® unveiled the National Law Enforcement Officer Hall of Fame Wall at its Lexington, Kentucky, corporate headquarters, displaying portraits of every past inductee into the National Law Enforcement Officer Hall of Fame. Recognition, made permanent...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 237

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 24

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 98

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
InPHRED's Award Brings 1310 nm VCSELs Into Focus at IEEE

Updated Category News Views 113

A stubborn mirror problem just put InPHRED on the photonics map. InPHRED, founded in 2023, took the Best Technology award at the inaugural 2026 IEEE Photonics Conference Start-Up Competition, selected from seven finalists. That is a meaningful industry pat on the back, particularly because the company is aiming at a real engineering headache rather than waving around...

Continue Reading
Vusion Lands a 2,000-Store dm EdgeSense Rollout in Germany

Updated Category News Views 10

A drugstore shelf rarely gets anyone's pulse racing, but 2,000 of them wired into a live digital system is a serious retail deployment. Vusion has expanded its partnership with dm-drogerie markt to roll out its newest EdgeSense platform across about 2,000 German stores over the next three years. This is not a glossy one-store pilot with a ribbon-cutting and a few tablets...

Continue Reading
Three Cash Buyouts Draw Fresh Shareholder Scrutiny

Updated Category News Views 0

Three cash-price tags landed on the tape with a lawyerly asterisk attached: are public holders actually getting a fair shake? On November 18, 2026, Halper Sadeh LLC said it was investigating proposed sales involving Surgery Partners, Braze and CCC Intelligent Solutions. That is not a finding of misconduct, and investors ought to keep that distinction bolted firmly to the...

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 291

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 114

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Rush to ExoraPad: The Rise of $EXP Tokens Explained

Updated Category News Views 219

Investors Flock to ExoraPad as the $EXP Token Presale Surges As the digital currency landscape evolves, many investors are seeking the next big opportunity. ExoraPad has emerged as a focal point in this space, particularly for those involved with XRP. The ongoing presale for the $EXP token has garnered immense attention, attracting numerous investors eager to secure their...

Continue Reading
Key Insights on DFDS A/S Share Transactions Involving Managers

Updated Category News Views 251

Recent Share Transactions by DFDS A/S Leadership On February 25, a significant transaction was recorded involving Claus V. Hemmingsen, the Chair of the Board of Directors for DFDS A/S, who purchased 5,000 shares of the company. This action showcases the confidence of the company’s leadership in its growth trajectory and operational strategy. Regulatory Obligations Under...

Continue Reading
First Guaranty Bancshares Reaches New Stock Milestone

Updated Category News Views 253

First Guaranty Bancshares Achieves New Milestone First Guaranty Bancshares Inc (NASDAQ: FGBI) has recently achieved a notable milestone, with its stock hitting a new 52-week high of $13.38. This impressive leap highlights a phase of robust growth for the company, reflected in the rising stock price that has been buoyed by favorable market sentiments. Over the past year,...

Continue Reading
Pho Hoa & Jazen Tea Expands Southeast with New Location

Updated Category News Views 314

Pho Hoa & Jazen Tea Expands into the Southeast Pho Hoa & Jazen Tea is excited to announce the grand opening of a new restaurant in Marietta, marking an important milestone in the brand's expansion strategy. With over 40 years dedicated to perfecting pho noodle soup, the company is eager to bring its incredible Vietnamese culinary experience to new customers. Exciting New...

Continue Reading
IDT Corporation's Commitment to Shareholders with New Dividend

Updated Category News Views 74

IDT Corporation Announces Quarterly Dividend for Shareholders IDT Corporation (NYSE: IDT), a key player in communications and payment services, has recently made waves by declaring a quarterly cash dividend of $0.05 per share. This news was shared through a regulatory filing, illustrating the company's ongoing commitment to providing value to its shareholders. Details on...

Continue Reading